Fountoulakis M - Search Results

1

Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal down syndrome brain.

Gulesserian T, Kim SH, Fountoulakis M, Lubec G. Gulesserian T, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2002 Feb 15;291(1):62-7. doi: 10.1006/bbrc.2002.6389. Biochem Biophys Res Commun. 2002. PMID: 11829462

2

Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).

Peyrl A, Weitzdoerfer R, Gulesserian T, Fountoulakis M, Lubec G. Peyrl A, et al. Among authors: fountoulakis m. Electrophoresis. 2002 Jan;23(1):152-7. doi: 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T. Electrophoresis. 2002. PMID: 11824616

3

Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain.

Weitzdoerfer R, Fountoulakis M, Lubec G. Weitzdoerfer R, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2002 May 3;293(2):836-41. doi: 10.1016/S0006-291X(02)00291-7. Biochem Biophys Res Commun. 2002. PMID: 12054546

4

Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome.

Kim SH, Fountoulakis M, Cairns NJ, Lubec G. Kim SH, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2002 Aug 30;296(4):970-5. doi: 10.1016/s0006-291x(02)02035-1. Biochem Biophys Res Commun. 2002. PMID: 12200143

5

Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex.

Bajo M, Fruehauf J, Kim SH, Fountoulakis M, Lubec G. Bajo M, et al. Among authors: fountoulakis m. Proteomics. 2002 Nov;2(11):1539-46. doi: 10.1002/1615-9861(200211)2:11<1539::AID-PROT1539>3.0.CO;2-C. Proteomics. 2002. PMID: 12442254

6

Reduced levels of DEAD-box proteins DBP-RB and p72 in fetal Down syndrome brains.

Kircher SG, Kim SH, Fountoulakis M, Lubec G. Kircher SG, et al. Among authors: fountoulakis m. Neurochem Res. 2002 Oct;27(10):1141-6. doi: 10.1023/a:1020921324871. Neurochem Res. 2002. PMID: 12462412

7

Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain.

Bernert G, Fountoulakis M, Lubec G. Bernert G, et al. Among authors: fountoulakis m. Proteomics. 2002 Dec;2(12):1752-7. doi: 10.1002/1615-9861(200212)2:12<1752::AID-PROT1752>3.0.CO;2-Y. Proteomics. 2002. PMID: 12469345

8

Expression of hypothetical proteins in human fetal brain: increased expression of hypothetical protein 28.5kDa in Down syndrome, a clue for its tentative role.

Engidawork E, Gulesserian T, Fountoulakis M, Lubec G. Engidawork E, et al. Among authors: fountoulakis m. Mol Genet Metab. 2003 Apr;78(4):295-301. doi: 10.1016/s1096-7192(03)00046-5. Mol Genet Metab. 2003. PMID: 12706381

9

Regulation of PCNA and CAF-1 expression by the two tuberous sclerosis gene products.

Hengstschläger M, Rosner M, Fountoulakis M, Lubec G. Hengstschläger M, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2003 Aug 1;307(3):737-42. doi: 10.1016/s0006-291x(03)01238-5. Biochem Biophys Res Commun. 2003. PMID: 12893285

10

Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.

Hengstschläger M, Rosner M, Fountoulakis M, Lubec G. Hengstschläger M, et al. Among authors: fountoulakis m. Biochem Biophys Res Commun. 2003 Dec 19;312(3):676-83. doi: 10.1016/j.bbrc.2003.10.170. Biochem Biophys Res Commun. 2003. PMID: 14680818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters